Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
New Analysis Reveals First-Line Treatment Data on SIR-Spheres® Y-90 Resin Microspheres for Patients with Liver Metastases from Right-Sided Primary Colon Cancer 2017-07-03 15:30
Metastatic Colorectal Cancer Patients Treated First-line with SIR-Spheres(R) Y-90 Resin Microspheres More Likely to Become Candidates for Potentially Curative Liver Surgery, REsect Study Shows 2017-05-24 16:10
SIR-Spheres(R) Y-90 Resin Microspheres Substantially Improves Quality of Survival in Primary Liver Cancer, New Study Against Standard Treatment Shows 2017-04-24 14:00
New European Society of Medical Oncology (ESMO) Biliary Cancer Guidelines Indicate Selective Internal Radiation Therapy (SIRT) with Y-90 Microspheres as an Option for Post-Chemotherapy Treatment of Intrahepatic Cholangiocarcinoma (iCCA) 2016-10-11 16:00
Patients with Colorectal Cancer Liver Metastases Had Significantly Greater Depth of Tumour Response to SIR-Spheres(R) Y-90 resin microspheres, New SIRFLOX Analysis Shows 2016-07-01 15:30
SIR-Spheres(R) Y-90 Resin Microspheres Are a Well-Tolerated Alternative to Standard Therapies for Inoperable Primary Liver Cancer, New UK NICE Medtech Innovation Briefing Says 2016-03-31 19:20
Netherlands Healthcare Institute Approves Reimbursement of Selective Internal Radiation Therapy (SIRT) for Patients with Colorectal Liver Metastases Who Have Failed Prior Treatment 2016-03-17 00:19
SIRFLOX Study Published in Journal of Clinical Oncology 2016-02-23 16:54
Treatment Results of SIR-Spheres® Y-90 Resin Microspheres are Similar Regardless of Patient Age, New Publication Shows 2016-01-20 04:42
SIRFLOX Study Presented at ASCO 2015 Annual Meeting 2015-06-01 09:06
Sirtex Reports Preliminary SIRFLOX Study Results 2015-03-23 16:07
Sirtex Reports Preliminary SIRFLOX Study Results 2015-03-17 15:28
FOXFIRE and FOXFIRE Global Studies Complete Patient Enrolment 2015-01-30 08:00
1